Form CORRESP - Correspondence:
SEC Accession No. 0001654954-25-004482
Filing Date
2025-04-21
Accepted
2025-04-21 16:03:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10470
  Complete submission text file 0001654954-25-004482.txt   11733
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)